Anzahl der Publikationen: 6
Zeitschriftenartikel
Kumbrink, Jorg; Bohlmann, Lisa; Mamlouk, Soulafa; Redmer, Torben; Peilstocker, Daniela; Li, Pan; Lorenzen, Sylvie; Alguel, Hana; Kasper, Stefan; Hempel, Dirk; Kaiser, Florian; Michl, Marlies; Bartsch, Harald; Neumann, Jens; Klauschen, Frederick; Bergwelt-Baildon, Michael von; Modest, Dominik Paul; Stahler, Arndt; Stintzing, Sebastian; Jung, Andreas; Kirchner, Thomas; Schäfer, Reinhold; Heinemann, Volker und Holch, Julian W.
(2022):
Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL.
In: Cancers, Bd. 14, Nr. 15
[PDF, 4MB]
Engler, Tobias; Fasching, Peter A.; Lueftner, Diana; Hartkopf, Andreas D.; Mueller, Volkmar; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Haeberle, Lothar; Ettl, Johannes; Wallwiener, Markus; Beckmann, Matthias W.; Hein, Alexander; Belleville, Erik; Uhrig, Sabrina; Wimberger, Pauline; Hielscher, Carsten; Kurbacher, Christian M.; Wuerstlein, Rachel; Untch, Michael; Taran, Florin-Andrei; Enzinger, Hans-Martin; Krabisch, Petra; Welslau, Manfred; Maasberg, Michael; Hempel, Dirk; Lux, Michael P.; Michel, Laura L.; Janni, Wolfgang; Wallwiener, Diethelm; Brucker, Sara Y.; Fehm, Tanja N. und Schneeweiss, Andreas
(2022):
Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT.
In: Geburtshilfe und Frauenheilkunde, Bd. 82, Nr. 10: S. 1055-1067
Gruenwald, Viktor; Pink, Daniel; Egerer, Gerlinde; Schalk, Enrico; Augustin, Marinela; Deinzer, Christoph K. W.; Kob, Viola; Reichert, Dietmar; Kebenko, Maxim; Brandl, Stephan; Hahn, Dennis; Lindner, Lars H.; Hoiczyk, Mathias; Ringsdorf, Uta; Hanker, Lars C.; Hempel, Dirk; De Rivas, Beatriz; Wismann, Tobias und Ivanyi, Philipp
(2022):
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial.
In: Cancers, Bd. 14, Nr. 21, 5234
Jilg, Stefanie; Hauch, Richard T.; Kauschinger, Johanna; Buschhorn, Lars; Odinius, Timo O.; Dill, Veronika; Müller-Thomas, Catharina; Herold, Tobias; Prodinger, Peter M.; Schmidt, Burkhard; Hempel, Dirk; Bassermann, Florian; Peschel, Christian; Götze, Katharina S.; Hoeckendorf, Ulrike; Haferlach, Torsten und Jost, Philipp J.
(2019):
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose.
In: Experimental Hematology & Oncology, Bd. 8, 9
Buchbeitrag
Diese Liste wurde am
Sat Dec 21 19:40:43 2024 CET
erstellt.